Aging population will drive growth of South Korea's health care industry, which will reach over $130 billion in 2014
Combined sales of prescription and over-the-counter (OTC) medicines in South Korea reached 13,330 billion won ($10.45 billion) in 2009, according to Business Monitor International, which points out that its first-quarter 2010 update of the market now using information provided by the Korea Pharmaceutical Manufacturers Association (KPMA) and macroeconomic data from its own country risk team.
Through to 2014 and 2019, BMI is forecasting respective compound annual growth rates (CAGRs) of 11.35% and 7.49% for total pharmaceutical sales in local currency terms.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Generics
| Headless Content Management with Blaze